Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus Eye Drops in Posner-Schlossman Syndrome
NCT04590183Unknown
- Sponsor
- Peking University
- Start
- Oct 2020
- Primary completion
- Aug 2021
- Countries
- 1
01
Overview
Randomised, open-label trial of tacrolimus in Glaucomatocyclitic crisis (PSS), sponsored by Peking University. Primary endpoint: Slit-lamp examination of the cornea at 4 weeks. Status: unknown.
02
Drugs
tacrolimus
03
Conditions
Glaucomatocyclitic crisis (PSS)
Beyond the preview
Go deeper on NCT04590183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04590183.